The field of focused ultrasound achieved many milestones in 2015. Researchers opened the blood-brain barrier for the first time and are eyeing uses for Alzheimer's and other diseases. Clinical trials are underway in depression and pediatric bone tumors, while others are being planned in cancer immunotherapy. Two devices earned FDA approval to treat the prostate, and we are awaiting a decision on another for essential tremor. The year ended with a swirl of publicity around John Grisham's new short book, The Tumor, which highlights this innovative technology to increase awareness among the general public.
Looking ahead, we aim to focus our efforts in 2016 on clearing the logjam in a number of clinical projects and helping to set the stage for a successful US launch for treating essential tremor. As always, we are thankful to our generous donors for helping to make this work possible.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.